DA
DCF Advisers Portfolio holdings
AUM
$208M
1-Year Return
21.52%
This Quarter Return
+4.03%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$194M
AUM Growth
+$2.85M
(+1.5%)
Cap. Flow
-$7.26M
Cap. Flow
% of AUM
-3.74%
Top 10 Holdings %
Top 10 Hldgs %
44.93%
Holding
90
New
4
Increased
18
Reduced
33
Closed
6
Top Buys
| 1 |
Amazon
AMZN
|
$3.26M |
| 2 |
Micron Technology
MU
|
$1.71M |
| 3 |
Citigroup
C
|
$1.47M |
| 4 |
Sprott Uranium Miners ETF
URNM
|
$1.15M |
| 5 |
Amgen
AMGN
|
$806K |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$2.79M |
| 2 |
Apple
AAPL
|
$2.33M |
| 3 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$1.2M |
| 4 |
Biohaven
BHVN
|
$1.03M |
| 5 |
SPDR Gold Trust
GLD
|
$972K |
Sector Composition
| 1 | Healthcare | 34.68% |
| 2 | Technology | 20.85% |
| 3 | Communication Services | 9.23% |
| 4 | Consumer Discretionary | 8.15% |
| 5 | Financials | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
VanEck Junior Gold Miners ETF
GDXJ
$6.8B
| $927K | 0.37% |
19,000
+5,300
| +39% | +$259K |
|
52
Marvell Technology
MRVL
$54.2B
| $902K | 0.36% |
12,500
-5,000
| -29% | -$361K |
|
53
Broadcom
AVGO
$1.43T
| $863K | 0.34% |
5,000
-4,750
| -49% | -$819K |
|
54
Evotec
EVO
$1.2B
| $792K | 0.32% |
217,055
+102,102
| +89% | +$373K |
|
55
Barnes & Noble Education
BNED
$283M
| $782K | 0.31% |
84,500
+7,000
| +9% | +$64.8K |
|
56
PayPal
PYPL
$64.6B
| $780K | 0.31% |
10,000
-1,000
| -9% | -$78K |
|
57
Burford Capital
BUR
$2.92B
| $690K | 0.28% |
52,000
| – | – |
|
58
Sanofi
SNY
$113B
| $634K | 0.25% |
11,000
| – | – |
|
59
Boeing
BA
$175B
| $631K | 0.25% |
4,150
-500
| -11% | -$76K |
|
60
Flutter Entertainment
FLUT
$51.5B
| $593K | 0.24% |
2,500
-700
| -22% | -$166K |
|
61
iShares MSCI Emerging Markets ETF
EEM
$18.9B
| $573K | 0.23% |
12,500
| – | – |
|
62
NewAmsterdam Pharma
NAMS
$2.78B
| $564K | 0.23% |
+34,000
| New | +$564K |
|
63
Teladoc Health
TDOC
$1.35B
| $482K | 0.19% |
52,500
| – | – |
|
64
Arq
ARQ
$311M
| $429K | 0.17% |
73,000
+51,000
| +232% | +$299K |
|
65
Royalty Pharma
RPRX
$15.8B
| $424K | 0.17% |
+15,000
| New | +$424K |
|
66
Lam Research
LRCX
$126B
| $408K | 0.16% |
5,000
| – | – |
|
67
Palo Alto Networks
PANW
$127B
| $342K | 0.14% |
2,000
| – | – |
|
68
Viridian Therapeutics
VRDN
$1.55B
| $330K | 0.13% |
14,500
-3,250
| -18% | -$73.9K |
|
69
Methanex
MEOH
$2.8B
| $310K | 0.12% |
+7,500
| New | +$310K |
|
70
Altimmune
ALT
$316M
| $233K | 0.09% |
37,868
-5,000
| -12% | -$30.7K |
|
71
AT&T
T
$211B
| $224K | 0.09% |
10,200
-37,500
| -79% | -$825K |
|
72
Nokia
NOK
$24.5B
| $219K | 0.09% |
50,000
| – | – |
|
73
Wolfspeed
WOLF
$194M
| $200K | 0.08% |
20,600
| – | – |
|
74
NextNav
NN
$2.09B
| $127K | 0.05% |
+17,000
| New | +$127K |
|
|
RVNC
75
DELISTED
Revance Therapeutics, Inc.
RVNC
| $101K | 0.04% |
19,417
-230,583
| -92% | -$1.2M |
|